The IMPACT to Save Moms Act would direct the Secretary of Health and Human Services, through CMS, to create a five-year demonstration project for fiscal years 2027 through 2031. The project would let states test alternative payment models for maternity care under Medicaid and CHIP for pregnant and postpartum individuals. The bill is aimed at encouraging payment structures that better support maternal health, especially for populations experiencing higher rates of maternal mortality, severe maternal morbidity, and other adverse perinatal outcomes.
In designing the demonstration, HHS would be required to consult a broad set of stakeholders, including state Medicaid programs, maternity care providers, patient advocates, community-based organizations, perinatal health workers, insurers, hospitals, midwives, birth centers, FQHCs, rural health clinics, researchers, and policy experts. The bill specifically encourages models that account for pregnancy risk, use evidence-based quality metrics, consider non-hospital birth settings, address social determinants of health, include diverse care teams, and incorporate maternal mental health and substance use disorder considerations.
The bill would not directly rewrite Medicaid or CHIP eligibility rules, but it would create a federal pilot program within those programs to test new payment approaches for maternity care. States would have to apply to participate, and HHS would evaluate the project’s effects on maternal outcomes, spending, and patient experience, with data broken down by race, ethnicity, language, socioeconomic status, geography, and insurance type. After the demonstration ends, HHS would report to Congress and recommend whether the model should continue or expand nationally.
Overall sentiment appears supportive and policy-oriented, with the bill framed as a maternal health improvement measure rather than a partisan overhaul. The text emphasizes evidence, stakeholder coordination, and targeted attention to disparities, suggesting a broad public-health rationale. No committee transcript or vote record was provided, so there is no recorded debate or formal vote sentiment to assess beyond the bill’s design.
Notable points of potential contention include the use of federal authority to steer state Medicaid and CHIP payment models, the administrative burden on states seeking to participate, and how payment adjustments would be tied to risk stratification and quality metrics. Stakeholders may also differ on the role of non-hospital birth settings, the inclusion of mental health and substance use treatment in maternity payment models, and whether the demonstration should eventually be expanded nationwide.
The bill would add a new federal demonstration project under the Social Security Act for Medicaid and CHIP maternity care payment models, but it would not itself mandate a nationwide payment change. It would affect state Medicaid and CHIP agencies, maternity care providers, hospitals, birth centers, and related stakeholders by creating an application-based pilot for alternative reimbursement approaches, with federal evaluation and reporting requirements. The measure authorizes such sums as necessary, but leaves implementation details to HHS and CMS.
The bill’s overall tone is constructive and reform-minded, with a clear focus on improving maternal outcomes and reducing disparities. Because no committee discussion or votes were provided, there is no evidence of organized opposition or support in the record beyond the bill’s text. The framing suggests likely bipartisan appeal around maternal health, though the details of payment reform could draw scrutiny from states and providers.
The main areas of possible contention are the scope of federal involvement in state Medicaid and CHIP payment design, the complexity of implementing risk-adjusted alternative payment models, and how performance would be measured across diverse populations and care settings. Some stakeholders may favor broader inclusion of birth centers, community-based care, and perinatal health workers, while others may question whether those approaches should be prioritized over hospital-based care. There may also be debate over how strongly the model should address social determinants, racial disparities, mental health, and substance use disorders within a payment demonstration.